Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
6,817.00
-70 (-1.02%)
BSENSE

May 25

BSE+NSE Vol: 6.61 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
2,831.00
2,604.00
2,715.00
2,410.00
2,585.00
2,319.00
2,338.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,831.00
2,604.00
2,715.00
2,410.00
2,585.00
2,319.00
2,338.00
Raw Material Cost
1,214.00
1,217.00
937.00
1,010.00
931.00
1,021.00
976.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-95.00
-272.00
136.00
-54.00
50.00
-99.00
-7.00
Employee Cost
381.00
367.00
354.00
340.00
350.00
297.00
304.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
397.00
402.00
400.00
385.00
368.00
357.00
349.00
Total Expenditure (Excl Depreciation)
1,897.00
1,714.00
1,827.00
1,681.00
1,699.00
1,576.00
1,622.00
Operating Profit (PBDIT) excl Other Income
934.00
890.00
888.00
729.00
886.00
743.00
716.00
Other Income
155.00
88.00
145.00
119.00
86.00
82.00
106.00
Operating Profit (PBDIT)
1,089.00
978.00
1,033.00
848.00
972.00
825.00
822.00
Interest
6.00
6.00
8.00
3.00
1.00
0.00
1.00
Exceptional Items
0.00
-74.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,083.00
898.00
1,025.00
845.00
971.00
825.00
821.00
Depreciation
120.00
118.00
113.00
112.00
107.00
99.00
99.00
Profit Before Tax
963.00
780.00
912.00
733.00
864.00
726.00
722.00
Tax
212.00
197.00
223.00
188.00
202.00
137.00
212.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
751.00
583.00
689.00
545.00
662.00
589.00
510.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
751.00
583.00
689.00
545.00
662.00
589.00
510.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
751.00
583.00
689.00
545.00
662.00
589.00
510.00
Equity Capital
53.00
53.00
53.00
53.00
53.00
53.00
53.00
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
28.34
22.0
26.0
20.57
24.98
22.23
19.25
Diluted Earnings per share
28.31
21.98
25.97
20.49
24.93
22.2
19.2
Operating Profit Margin (Excl OI)
32.99%
34.18%
32.71%
30.25%
34.27%
32.04%
30.62%
Gross Profit Margin
38.26%
34.49%
37.75%
35.06%
37.56%
35.58%
35.12%
PAT Margin
26.53%
22.39%
25.38%
22.61%
25.61%
25.4%
21.81%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 8.72% vs -4.09% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 28.82% vs -15.38% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 4.94% vs 0.23% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 0.00% vs -25.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Divi's Lab. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
2,831.00
14,611.79
-11,780.79
-80.63%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,831.00
14,611.79
-11,780.79
-80.63%
Raw Material Cost
1,214.00
2,182.44
-968.44
-44.37%
Purchase of Finished goods
0.00
753.34
-753.34
-100.00%
(Increase) / Decrease In Stocks
-95.00
-134.69
39.69
29.47%
Employee Cost
381.00
2,960.41
-2,579.41
-87.13%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
397.00
4,896.09
-4,499.09
-91.89%
Total Expenditure (Excl Depreciation)
1,897.00
10,657.59
-8,760.59
-82.20%
Operating Profit (PBDIT) excl Other Income
934.00
3,954.20
-3,020.20
-76.38%
Other Income
155.00
458.50
-303.50
-66.19%
Operating Profit (PBDIT)
1,089.00
4,412.70
-3,323.70
-75.32%
Interest
6.00
85.89
-79.89
-93.01%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,083.00
4,326.81
-3,243.81
-74.97%
Depreciation
120.00
775.47
-655.47
-84.53%
Profit Before Tax
963.00
3,551.34
-2,588.34
-72.88%
Tax
212.00
827.62
-615.62
-74.38%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
751.00
2,723.72
-1,972.72
-72.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
751.00
2,723.72
-1,972.72
-72.43%
Share in Profit of Associates
0.00
-14.06
14.06
100.00%
Minority Interest
0.00
-4.37
4.37
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
751.00
2,714.03
-1,963.03
-72.33%
Equity Capital
53.00
239.93
-186.93
-77.91%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
28.34
11.31
17.03
150.57%
Diluted Earnings per share
28.31
11.30
17.01
150.53%
Operating Profit Margin (Excl OI)
32.99%
27.16%
0.00
5.83%
Gross Profit Margin
38.26%
29.72%
0.00
8.54%
PAT Margin
26.53%
18.71%
0.00
7.82%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,831.00 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 8.72% vs -4.09% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 9.52% vs 12.24% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 751.00 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 28.82% vs -15.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 13.44% vs 23.05% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 934.00 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.94% vs 0.23% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 5.42% vs 21.20% in Mar 2025

Quarterly - Interest
Interest 6.00 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs -25.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 500.00% vs -50.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.99%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025